Introducing Kardia 12L: The first of its kind 12-lead portable ECG | Learn More

AliveCor Logo

Our Products

AFib Screening
Data Integration Solutions
KardiaCare Plus
KardiaComplete
Kardia 12L

New

KardiaMobile 6L
AliveCor K1000
KardiaStation
KardiaPro
Kardia ECG Devices

Our Solutions

Health Systems
Clinical Trials
Payors
Employers
OEMs
Veterans Affairs

About

Leadership
Mission
Clinical Research
Our AI
For Consumers
The Human Component Film
Newsroom
(855) 338-8800
AliveCor Logo
AliveCor Logo
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
    • (855) 338-8800
    • Mission
    • Careers
    • Research
    • Newsroom
    • FAQs
    • User Manuals
    • Compatibility
    • Shipping
    • (855) 338-8800
    • KardiaMobile Card
    • KardiaMobile 6L
    • KardiaMobile
    • KardiaCare
    • International
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • Privacy Policy
  • Security
  • Telehealth Informed Consent
  • Terms
  • Accessibility

©2024 AliveCor, Inc. All Rights Reserved. Patents www.alivecor.com/patents. AliveCor and Kardia are trademarks of AliveCor, Inc. in the United States and other countries. Apple is a trademark of Apple, Inc. registered in the U.S. and other countries. App Store is a service mark of Apple, Inc. Android is a trademark of Google Inc. Google Play is a trademark of Google Inc.

Go Back
AliveCor Mobile ECG Device for Heart Rhythm Monitoring Now Available by Prescription
SAN FRANCISCO Calif., March 8, 2013

On Display at ACC.13

AliveCor, Inc. announced today that its mobile Heart Monitor for iPhone is now available by prescription to enable patients to record their heart rhythm anytime, anywhere. The Heart Monitor, which makes home cardiac assessment quick and easy, is the first FDA-cleared mobile device–based ECG monitor that is compatible with iPhone4 and 4S. The device will be demonstrated at Booth #S708 (Expo South) at the ACC.13 annual meeting of the American College of Cardiology March 9 through March 11 in San Francisco.

The convenient and portable AliveCor Heart Monitor, formerly available only to U.S. medical professionals and now to patients by prescription, is enhancing the way patient arrhythmias are screened and monitored. All it takes is placing one’s fingers on the sensors; there are no leads to attach or special preparation needed. The accessibility makes recording ECGs easy when symptoms arise and can increase patient compliance and overall satisfaction. ECG readings are instantly displayed on the iPhone screen. The Heart Monitor is available for purchase by medical professionals and by prescription for $199 at www.alivecor.com .

“The AliveCor Heart Monitor is truly disruptive,” said Hugo Campos, e-patient and member of the Society for Participatory Medicine. “It helps me capture episodes when they happen and helps me understand how to avoid them. It’s now possible to record our ECG rhythm whenever we want and share it with whomever we want.”

Clinical studies of the device indicate that a high-quality single-channel ECG can be rapidly and simply recorded using an iPhone with the AliveCor application and device, allowing accurate screening for cardiac arrhythmias including atrial fibrillation. Atrial fibrillation is the most commonly occurring arrhythmia and carries a five-fold risk of stroke.

“The ability for doctors to prescribe this device to patients is a real breakthrough to help patients participate in their health and work with their physicians to truly collaborate on their care,” said Dr. Dave Albert, CMO and co-founder of AliveCor.

The AliveCor Heart Monitor snaps onto the back of an iPhone, like a case, to record, display, store, and transfer single-channel electrocardiogram (ECG) rhythms wirelessly with the corresponding, free AliveECG app. No pairing between the iPhone and Heart Monitor is required.

Let's transform cardiovascular care together

If you are an employer or payer looking for a comprehensive heart health enterprise solution, contact us.